share_log

HC Wainwright & Co. Upgrades Alaunos Therapeutics to Buy, Announces $1.5 Price Target

Benzinga ·  May 15, 2023 07:21

HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Alaunos Therapeutics (NASDAQ:TCRT) from Neutral to Buy and announces $1.5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment